Solara Active Pharma (SOLARA) | Stock Overview & Key Data
Solara Active Pharma Performance Comparison
Stock Range
Today's Range
Low: ₹656.10
High: ₹681.00
on September 5, 2025
52 Week Range
Low: ₹442.80
High: ₹882.80
on March 4, 2025
on December 2, 2024
All-Time High: ₹1,859.95 on May 17, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR29.5B
EPS
6.13
P/E Ratio (TTM)
108.44
Forward P/E
20.45
P/B Ratio
2.45
PEG Ratio
-0.64
Div. Yield
N/A
ROE
0.05%
Beta
1.030
Debt to Equity
72.58
Financial Highlights
Profitability
Gross Margin
54.11%
Operating Margin
10.48%
Profit Margin
1.98%
Returns and Earnings
Return on Assets (TTM)
0.02%
Return on Equity (TTM)
0.05%
EBITDA
INR2.3B
Net Income (TTM)
INR245.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR257.93
Quarterly Revenue Growth (YoY)
-12.20%
Quarterly Earnings Growth (YoY)
-12.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Solara Active Pharma SOLARA | 29.51B Small-cap | 8.45% | 11.76% | 40.58% | 34.05% | -5.23% | -10.99% | 48.78% | -32.12% |
| Sun Pharmaceutical SUNPHARMA | 3.90T Large-cap | -0.06% | -2.36% | -5.32% | 0.70% | -15.68% | -12.66% | 79.06% | 215.22% |
| Divi's Laboratories DIVISLAB | 1.61T Large-cap | -2.00% | -6.24% | -9.35% | 8.93% | -1.05% | 16.96% | 66.78% | 90.96% |
| Sun Pharma Advanced SPARC | 47.12B Small-cap | 3.48% | -0.53% | -10.54% | 16.34% | -27.77% | -35.78% | -37.21% | -17.87% |
| Sequent Scientific SEQUENT | 45.94B Small-cap | 8.53% | 2.74% | -4.58% | 20.89% | -0.45% | 5.84% | 58.46% | 26.24% |
| Aarti Drugs AARTIDRUGS | 43.34B Small-cap | 0.34% | -2.15% | 1.71% | 29.45% | 3.44% | -14.90% | 0.36% | -33.81% |
Ownership & Short Interest
Insider Ownership
52.40%
Institutional Ownership
21.52%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
108K
Average 90-Day Volume
142K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SOLARA's 52-week high and low?
- In the last 52 weeks, Solara Active Pharma reached a high of ₹882.80 (on December 2, 2024) and a low of ₹442.80 (on March 4, 2025).
- What is the market cap and P/E ratio for SOLARA?
- Curious about Solara Active Pharma's size and valuation? Its market capitalization stands at 29.51B. When it comes to valuation, the P/E ratio (trailing twelve months) is 108.44, and the forward P/E (looking ahead) is 20.45.
- Does SOLARA pay dividends? If so, what's the yield?
- As for dividends, Solara Active Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Solara Active Pharma's main competitors or similar companies to consider before investing?
When looking at Solara Active Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.90T Healthcare Drug Manufacturers - Specialty & Generic -12.66% 79.06% Divi's Laboratories
DIVISLAB1.61T Healthcare Drug Manufacturers - Specialty & Generic 16.96% 66.78% Sun Pharma Advanced
SPARC47.12B Healthcare Drug Manufacturers - Specialty & Generic -35.78% -37.21% Sequent Scientific
SEQUENT45.94B Healthcare Drug Manufacturers - Specialty & Generic 5.84% 58.46% Aarti Drugs
AARTIDRUGS43.34B Healthcare Drug Manufacturers - Specialty & Generic -14.90% 0.36% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Solara Active Pharma Sciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Solara Active Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.05%, the Debt to Equity ratio from the most recent quarter is 72.58, and its Gross Profit Margin stands at 54.11%.
- What is the recent revenue and earnings growth for SOLARA?
- Looking at Solara Active Pharma's growth, its revenue over the trailing twelve months (TTM) was INR12B. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.20%, and quarterly earnings saw a YoY growth of -12.20%.
- How much of SOLARA stock is held by insiders and institutions?
- Wondering who owns Solara Active Pharma stock? Company insiders (like executives and directors) hold about 52.40% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 21.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.